The SPIN works in close collaboration with National Representatives, gathering the representatives of the national psoriasis groups who participate to the network. We currently surveying in order to include key opinion leaders on atopic dermatitis at the national level.
SPIN National Representatives are in a privileged position to relay the information about SPIN’s projects, surveys and events at the national level. They have kindly accepted to be the national contact for all kind of collaborations, especially to promote the development of the network’s activities and the exchanges on psoriasis and atopic dermatitis all around the world. Each representative is responsible for the coordination of international collaborations between his or her country and the others, and of course for the participation to the projects around psoriasis and atopic dermatitis at the national level.
SPIN National Representatives will be solicited for input in the organisation of the scientific programme of the SPIN Congress taking place every three years. During the Congress, the National Representatives shall meet to foresee the next Congress and to choose the national or regional group that will be responsible for the scientific organisation of the following Congress.
Please find here below the list of SPIN National Representatives (this list shall be updated regularly):
Aomar AMMAR-KHODJA - Algeria
Nélida RAIMONDO- Argentina
Pablo FERNÁNDEZ-PEÑAS - Australia
Patrick BRUNNER- Austria
Uladzimir ADASKEVICH - Belarus
Michel DE LA BRASSINNE - Belgium
Félix ATADOKPEDE - Benin
Juan Carlos DIEZ DE MEDINA - Bolivia
Asja PROHIC - Bosnia and Herzegovina
Luna AZULAY - Brazil
Nikolai TSANKOV - Bulgaria
Fatou BARRO TRAORE - Burkina Faso
Christine MADENGUE - Cameroon
Chih-ho HONG - Canada
Claudia DE LA CRUZ - Chile
Min ZHENG - China
Chih-Hung LEE - Chinese Taipei
Cesar GONZALEZ A. - Colombia
Laura ALVAREZ MORALES - Costa Rica
Abdoulaye SANGHARE - Cote d’Ivoire
Romana CEOVIC - Croatia
Orestes BLANCO G. - Cuba
Jana HERCOGOVA - Czech Republic
Robert GNIADECKI - Denmark
Lars IVERSEN - Denmark
Alexandra ESPINAL - Dominican Republic
Emad ELGAMAL - Egypt
Leana QUINTANILLA - El Salvador
Jaime MARTINEZ LOPEZ - El Salvador
Külli KINGO- Estonia
Tarja MALKONEN - Finland
Carle PAUL - France
Sophie CONIQUET - Gabon
Nino CHIJAVADZE - Georgia
Tsira LEONIDZE - Georgia
Matthias AUGUSTIN - Germany
Christina ANTONIOU - Greece
Mohamed CISSE - Guinea
Ligia RAMOS - Honduras
Patricia MEJIAS - Honduras
Rolland Gyulai - Hungary
Jon Hjaltalin OLAFSSON - Iceland
Alur S. KUMAR - India
Benny E. WIRYADI- Indonesia
Omid ZARGARI - Iran
Brian KIRBY - Ireland
Lev PAVLOVSKY - Israel
Luigi NALDI - Italy
Hidemi NAKAGAWA - Japan
Laith AKKASH - Jordan
Joo Heung Lee- Korea
Nawaf AL MUTAIRI - Kuwait
Andris RUBINS - Latvia
Abdul Ghani KIBBI - Lebanon
Gamal A. DUWEB - Libya
Skaidra VALIUKEVICIENE - Lithuania
Emilija MANASIEVSKA - Macedonia
Azura Mohd AFFANDI- Malaysia
Ousmane FAYE - Mali
Michael BOFFA - Malta
Mamadou BALL - Mauritania
Gladys LEON DORANTES - Mexico
Boris NEDELCIUC - Moldova
Fatima Zahra MERNISSI- Morocco
Phyllis I. SPULS - Netherlands
Jorge NEIRA - Nicaragua
Ousmane KONATE - Niger
Abel Nze ONUNU - Nigeria
Riad MASHAL - Palestine
Giuliana CASTRO - Peru
Maria Lorna FREZ - Philippines
Jacek SZEPIETOWSKI - Poland
Hugo OLIVEIRA - Portugal
Hassan RIAD - Qatar
George-Sorin TIPLICA - Romania
Nikolay POTEKAEV- Russia
Serge SKREK- Russia
Iqbal A. BUKHARI - Saudi Arabia
Fatimata LY - Senegal
Ljiljana MEDENICA - Serbia
Colin THENG - Singapore
Slavomir URBANCEK - Slovakia
Tomaz LUNDER - Slovenia
Luis PUIG - Spain
Mona STAHLE - Sweden
Nikhil YAWALKAR - Switzerland
Fouz HASSAN - Syria
Pravit ASAWANONDA - Thailand
Vincent Pitche - Togo
Nejib DOSS - Tunisia
Mehmet Ali GURER - Turkey
Fayza AL ALI- United Arab Emirates
Christopher GRIFFITHS - United Kingdom
Mark LEBWOHL - United States of America
Oleksandr LITUS - Ukraine
Carlos CARMONA - Uruguay
Erika PAEZ - Venezuela
Alfredo LANDER - Venezuela
Aiman ALSHAMI - Yemen
SPIN Presentation
Recent news
- 2019/04/18 Focus on...
- 2019/04/17 Focus on...
- 2018/07/16 Focus on...
- 2018/07/09 Focus on...
News from the web office
- 2016/10/29
- 2016/05/26
- 2016/02/20
Events
- 2019/04/18 Focus on...
- 2018/02/21
News from medical groups
- 2018/04/18
- 2017/06/21
News from patients associations
- 2017/02/08
- 2016/05/26
Recent publications on Psoriasis and Atopic Dermatitis
on Psoriasis
Psoriasis and acute coronary syndrome risk.
Sachinidis A et al.
Psoriasis and acute coronary syndrome risk.
Int. J. Cardiol..
2019 Jul 01, 286:15-16.
Association of plasma and urine metals levels with kidney function: A population-based cross-sectional study in China.
Chemosphere.
2019 Jul , 226:321-328.
Although environmental exposure to multiple metals is common, epidemiological studies on the associations of exposure to 23 metals with kidney function have not been analyzed. We aimed to investigate the associations of 23 metals levels with renal function.
see on pubmed
Models of human psoriasis: Zebrafish the newly appointed player.
Martínez-Navarro FJ et al.
Models of human psoriasis: Zebrafish the newly appointed player.
Dev. Comp. Immunol..
2019 Aug , 97:76-87.
Psoriasis is a human chronic, immune disease with severe cutaneous and systemic manifestations. Its prevalence, among the world population, highly varies with ethnicity and geography, but not sex from remarkable low levels in Asia to 2.3% in Spain, or an impressive 11.5% in Norway. The pathogenesis of psoriasis derives from complex genetic and environmental interactions, which creates aberrant crosstalk between keratinocytes and variated immune cell, resulting in open amplified inflammatory (...)
see on pubmed
on Atopic Dermatitis
What's new in atopic eczema? An analysis of systematic reviews published in 2016. Part 3: nomenclature and outcome assessment.
Clin. Exp. Dermatol..
2019 Jun , 44, (4):376-380.
This review forms part of a series of annual updates that summarize the evidence base for atopic eczema (AE). It presents the key findings from 11 systematic reviews published in 2016 that focus on AE outcome assessment, disease impact and nomenclature. Systematic reviews on the treatment and prevention of AE are summarized in Part 1 of this update, and systematic reviews on the epidemiology of and risk factors for AE are summarized in Part 2. Six reviews summarized what outcome measurement (...)
see on pubmed
Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signaling.
Bioorg. Med. Chem. Lett..
2019 Jun 15, 29, (12):1522-1531.
Disruption of interleukin-13 (IL-13) signaling with large molecule antibody therapies has shown promise in diseases of allergic inflammation. Given that IL-13 recruits several members of the Janus Kinase family (JAK1, JAK2, and TYK2) to its receptor complex, JAK inhibition may offer an alternate small molecule approach to disrupting IL-13 signaling. Herein we demonstrate that JAK1 is likely the isoform most important to IL-13 signaling. Structure-based design was then used to improve the (...)
see on pubmed
Effect of cinnamamides on atopic dermatitis through regulation of IL-4 in CD4 cells.
Choi EJ et al.
Effect of cinnamamides on atopic dermatitis through regulation of IL-4 in CD4 cells.
J Enzyme Inhib Med Chem.
2019 Dec , 34, (1):613-619.
This study aimed to evaluate the effects of cinnamamides on atopic dermatitis (AD) and the mechanisms underlying these effects. To this end, the actions of two cinnamamides, (E)-3-(4-hydroxyphenyl)-N-phenylethyl acrylamide (NCT) and N-trans-coumaroyltyramine (NCPA), were determined on AD by orally administering them to mice. Oral administration of the cinnamamides ameliorated the increase in epidermal and dermal thickness as well as mast cell infiltration. Cinnamamides suppressed serum (...)
see on pubmed
